Bactiguard enters new therapeutic area through license agreement
Bactiguard and Smartwise Sweden AB (Smartwise) have entered into a joint development project for advanced, Bactiguard-coated vascular injection catheters. At the same time, a license agreement has been signed. Smartwise will pay USD 2.5 million, for the exclusive and global right to the Bactiguard technology for this application, payable in 2017, and followed by royalty payments once the products are commercialized.“We are very excited about the partnership with Smartwise, as it expands our technology to a completely new application area. Delivering drugs and other therapies to vital organs